Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Report ID | 577 |
Drug Identification Number | 02308452 |
Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Common or Proper name | PIPERACILLIN - TAZOBACTUM |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
Strength(s) | 3.0G 0.375G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 30 ML |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-09-07 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-09-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-09-12 | French | Compare |
v6 | 2018-09-12 | English | Compare |
v5 | 2018-09-11 | English | Compare |
v4 | 2018-09-10 | French | Compare |
v3 | 2018-09-10 | English | Compare |
v2 | 2017-03-11 | French | Compare |
v1 | 2017-03-11 | English | Compare |
Showing 1 to 7 of 7